Pacific Bio (PACB) Misses Q1 EPS by 1c, Miss on Revenues

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $19.4 million versus the consensus estimate of $24.54 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Grafton Group PLC (GFTU:LN) PT Raised to GBP11.50 at Berenberg
• ExxonMobil outlines key factors for Q2 2026 earnings outlook